Yi‐Wu Dang

机构：Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University · ORCID：0000-0002-7793-1239

发表论文 181 篇 · 总被引 3380 次 · h-index 30

代表论文

• ITGB4 Serves as an Identification and Prognosis Marker Associated with Immune Infiltration in Small Cell Lung Carcinoma (2023 · Molecular Biotechnology · 被引 27)
• MMP12 serves as an immune cell–related marker of disease status and prognosis in lung squamous cell carcinoma (2023 · PeerJ · 被引 18)
• CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers (2023 · BMC Pulmonary Medicine · 被引 16)
• Preoperative prediction of VETC in hepatocellular carcinoma using non-Gaussian diffusion-weighted imaging at high b values: a pilot study (2023 · Frontiers in Oncology · 被引 12)
• Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner (2025 · Molecular Medicine · 被引 11)
• Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry (2023 · European journal of medical research · 被引 9)